Search | IOVS | ARVO Journals

Showing 1 – 20 of 45

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Patient-reported visual functioning in persons with bi-allelic USH2A variants

Elise Heon; B. Michele Melia; Laura E Bocchino; Jacque L Duncan; Allison Ayala; Chris Bradley; Isabelle Audo; Janet K Cheetham; Gislin Dagnelie; Todd Durham; Carel Hoyng; Nieraj Jain; Thiran Jayasundera; Mark E Pennesi; Christina Y Weng

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3541. doi:

ARVO Annual Meeting Abstract June 2021

The prevalence, visual significance, and genotype-phenotype associations of foveal hypoplasia in inherited retinal diseases

Rebhi Abuzaitoun; Kari Branham; Dana Schlegel; Thiran Jayasundera; Abigail T Fahim

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3232. doi:

ARVO Annual Meeting Abstract June 2021

Factors Affecting Rates of Genetic Testing for Inherited Retinal Degenerations

Peter Yu Cheng Zhao; Kari E Branham; Dana Schlegel; Abigail T Fahim; Thiran Jayasundera

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):162. doi:

Articles June 2020

Correlation of Immunological Markers with Disease and Clinical Outcome Measures in Patients with Autoimmune Retinopathy

PDF

Lynn K. Stanwyck; Weilin Chan; Arjun Sood; Gayatri Susarla; John Romano; Maria Pefkianaki; Kanishka Thiran Jayasundera; John R. Heckenlively; Steven K. Lundy; Lucia Sobrin
TAGS: autoimmunity, retinal diseases, treatment outcome, b-lymphocytes
Trans. Vis. Sci. Tech.. 2020; 9(7):15. doi: https://doi.org/10.1167/tvst.9.7.15

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

Adherence and Satisfaction in Argus II Prosthesis Users: A Self Determination Theory Model

Mariam Khan; Kari E Branham; Thiran Jayasundera; Naheed W Khan

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):928. doi:

ARVO Annual Meeting Abstract June 2020

Development of a validated patient-reported outcomes measure for retinal dystrophy therapeutics

Gabrielle Lacy; Maria Fernanda Abalem; Natasha Baig; Hanan Rakine; Chris A Andrews; Joshua R Ehrlich; David Musch; Thiran Jayasundera

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1564. doi:

Review June 2020

Advancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano Symposium

PDF

Debra A. Thompson; Alessandro Iannaccone; Robin R. Ali; Vadim Y. Arshavsky; Isabelle Audo; James W. B. Bainbridge; Cagri G. Besirli; David G. Birch; Kari E. Branham; Artur V. Cideciyan; Steven P. Daiger; Deniz Dalkara; Jacque L. Duncan; Abigail T. Fahim; John G. Flannery; Roberto Gattegna; John R. Heckenlively; Elise Heon; K. Thiran Jayasundera; Naheed W. Khan; Henry Klassen; Bart P. Leroy; Robert S. Molday; David C. Musch; Mark E. Pennesi; Simon M. Petersen-Jones; Eric A. Pierce; Rajesh C. Rao; Thomas A. Reh; Jose A. Sahel; Dror Sharon; Paul A. Sieving; Enrica Strettoi; Paul Yang; David N. Zacks; The Monaciano Consortium
TAGS: outcome measures, retinal diseases, surrogate endpoints, genetics, vision, natural history, ethics, gene therapy
Trans. Vis. Sci. Tech.. 2020; 9(7):2. doi: https://doi.org/10.1167/tvst.9.7.2

Articles September 2019

Comparison of Fundus-Guided Microperimetry and Multifocal Electroretinography for Evaluating Hydroxychloroquine Maculopathy

PDF

Husam Alghanem; Tapas R. Padhi; Adrienne Chen; Leslie M. Niziol; Maria Fernanda Abalem; Natalie Dakki; Timothy Steffens; Chris Andrews; David C. Musch; K. Thiran Jayasundera; Naheed W. Khan
TAGS: electroretinography, eye, hydroxychloroquine, macular disorders, spectral domain-optical coherence tomography, toxic effect, sensitivity and specificity
Trans. Vis. Sci. Tech.. 2019; 8(5):19. doi: https://doi.org/10.1167/tvst.8.5.19

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Correlation of immunohistochemical markers with disease and clinical outcome measures in patients with autoimmune retinopathy

Weilin Chan; Lynn Stanwyck; Arjun sood; John Romano; Maria Pefkianaki; Thiran Jayasundera; John R Heckenlively; Steven K Lundy; Lucia Sobrin

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6676. doi:

ARVO Annual Meeting Abstract July 2019

Expanded clinical spectrum of pentosan polysulfate sodium-associated pigmentary maculopathy

Adam Marcus Hanif; Stanford Taylor; Stephen Armenti; Rachel Shah; Austin Igelman; Mark E Pennesi; Thiran Jayasundera; Paul Yang; Thomas S Hwang; Christina J Flaxel; Rahul Khurana; Joshua D Stein; Nieraj Jain

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3245. doi:

Retina December 2018

Prospective Evaluation of Patients With X-Linked Retinoschisis During 18 Months

PDF

Mark E. Pennesi; David G. Birch; K. Thiran Jayasundera; Maria Parker; Ou Tan; Rabia Gurses-Ozden; Carrie Reichley; Kathleen N. Beasley; Paul Yang; Richard G. Weleber; Lea D. Bennett; John R. Heckenlively; Kalyani Kothapalli; Jeffrey D. Chulay; for the XLRS-001 Study Group
TAGS: cysts, electroretinography, eye, perimetry, vision, visual acuity, volume, x-linked retinoschisis, contrast sensitivity, cutaneous collagenous vasculopathy
Invest. Ophthalmol. Vis. Sci.. 2018; 59(15):5941-5956. doi: https://doi.org/10.1167/iovs.18-24565

Includes: Supplemental Content

Retina January 2018

Approach for a Clinically Useful Comprehensive Classification of Vascular and Neural Aspects of Diabetic Retinal Disease

PDF

Michael D. Abramoff; Patrice E. Fort; Ian C. Han; K. Thiran Jayasundera; Elliott H. Sohn; Thomas W. Gardner
TAGS: diabetes mellitus, retinal diseases, diagnostic imaging, dorsal raphe nucleus
Invest. Ophthalmol. Vis. Sci.. 2018; 59(1):519-527. doi: https://doi.org/10.1167/iovs.17-21873

ARVO Annual Meeting Abstract June 2017

Optical coherence tomography examination of the retinal pigment epithelium and vitelliform lesions in Best vitelliform macular dystrophy

Cynthia Xin-Ya Qian; Dionisio Charran; Cameron R Strong; Timothy J Steffens; Thiran Jayasundera; John Heckenlively

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3229. doi:

ARVO Annual Meeting Abstract June 2017

Argus II Retinal Prosthesis System Post-Approval US Cohort 1 Year Outcomes

Aleksandra V Rachitskaya; Jessy Dana Dorn; Hossein Ameri; David G Birch; Raymond Iezzi; Allen Ho; Thiran Jayasundera; Gregg Kokame; Jennifer I Lim; Naresh Mandava; Lejla Vajzovic; Jiong Yan; Meghan J Marino; Alex Yuan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4264. doi:

ARVO Annual Meeting Abstract June 2017

OCT Characteristics Among Subjects Implanted with the Argus II Retinal Prosthesis System; the Argus II OCT Study Group

Catherine Hoeppner; Natalia F Callaway; Ninel Gregori; Byron L Lam; Hossein Ameri; Albert J Augustin; Allen Ho; Raymond Iezzi; Thiran Jayasundera; Gregg Kokame; Jennifer I Lim; Peter Szurman; Lejla Vajzovic; Peter MH Wiedemann; Jiong Yan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4267. doi:

ARVO Annual Meeting Abstract June 2017

Peripheral pigmented lesions in Stargardt disease

Maria Fernanda Abalem; Peter Yu Cheng Zhao; Daniel Nadelman; Cynthia Xin-Ya Qian; Kari E Branham; Dana Schlegel; Naheed Wali Khan; John R Heckenlively; Thiran Jayasundera

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3262. doi:

ARVO Annual Meeting Abstract June 2017

Inheritance Pattern Prediction of Retinal Dystrophies: A Machine-Learning Model

Dana Schlegel; Edmond Cunningham; Xinghai Zhang; Yaman Abdulhak; Andrew DeOrio; Thiran Jayasundera

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5586. doi:

ARVO Annual Meeting Abstract June 2017

eQUEST: The eSight QUality of life and Efficacy STudy

Walter Wittich; Marie-Celine Lorenzini; Judith E Goldstein; Samuel N Markowitz; Beatriz E Patino; Kristen Lindeman; Sonya Braudway; Scott A Gartner; Lindsay Godsay; Ashley Howson; Michael Tolentino; Thiran Jayasundera; Sophia Reyes; Gislin Dagnelie

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4764. doi:

ARVO Annual Meeting Abstract June 2017

Natural History and Effect of Carbonic Anhydrase Inhibitor Use in X-Linked Retinoschisis

Maria A Parker; David G Birch; Thiran Jayasundera; Laura R Erker; Rabia Gurses-Ozden; Kathleen Beasley; Jeffrey D Chulay; Mark E Pennesi

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1490. doi:

ARVO Annual Meeting Abstract June 2017

Importance of Checking for Active Autoimmunity in Genetically-Confirmed Retinal Dystrophy Patients

Steven K Lundy; Athanasios J Karoukis; Ray Ohara; Enayat Nikoopour; Mohammad I Othman; Maria Fernanda Abalem; Thiran Jayasundera; Kari E Branham; John R Heckenlively

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):556. doi:

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Patient-reported visual functioning in persons with bi-allelic USH2A variants

The prevalence, visual significance, and genotype-phenotype associations of foveal hypoplasia in inherited retinal diseases

Factors Affecting Rates of Genetic Testing for Inherited Retinal Degenerations

Correlation of Immunological Markers with Disease and Clinical Outcome Measures in Patients with Autoimmune Retinopathy

Adherence and Satisfaction in Argus II Prosthesis Users: A Self Determination Theory Model

Development of a validated patient-reported outcomes measure for retinal dystrophy therapeutics

Advancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano Symposium

Comparison of Fundus-Guided Microperimetry and Multifocal Electroretinography for Evaluating Hydroxychloroquine Maculopathy

Correlation of immunohistochemical markers with disease and clinical outcome measures in patients with autoimmune retinopathy

Expanded clinical spectrum of pentosan polysulfate sodium-associated pigmentary maculopathy

Prospective Evaluation of Patients With X-Linked Retinoschisis During 18 Months

Approach for a Clinically Useful Comprehensive Classification of Vascular and Neural Aspects of Diabetic Retinal Disease

Optical coherence tomography examination of the retinal pigment epithelium and vitelliform lesions in Best vitelliform macular dystrophy

Argus II Retinal Prosthesis System Post-Approval US Cohort 1 Year Outcomes

OCT Characteristics Among Subjects Implanted with the Argus II Retinal Prosthesis System; the Argus II OCT Study Group

Peripheral pigmented lesions in Stargardt disease

Inheritance Pattern Prediction of Retinal Dystrophies: A Machine-Learning Model

eQUEST: The eSight QUality of life and Efficacy STudy

Natural History and Effect of Carbonic Anhydrase Inhibitor Use in X-Linked Retinoschisis

Importance of Checking for Active Autoimmunity in Genetically-Confirmed Retinal Dystrophy Patients

To View More...

You must be signed into an individual account to use this feature.